Discover the latest research at our Top 10 Poster Presentations. Each presenter will have 3 minutes to present and 2 minutes for Q&A, offering a quick yet insightful look at their studies.

📱 Vote for the Best Poster via the ICLE 2026 mobile app and help select the top research! The winners will be announced during the closing session.

Date: 16 July
Time: 12:40 – 13:50
Location: Exhibition Hall

Moderator:
Marion Subklewe
LMU, Germany
Katia Palmisano

IRCCS San Raffaele Scientific Institute
Italy

COMBINATORIAL STRATEGY FOR IMPROVED CDH17 CAR T CELL THERAPY OF LIVER METASTASES FROM COLORECTAL CANCER

🕛 12:40 – 12:45

Christian Pellegrino

Philochem AG
Switzerland

IMPROVED CAR T-CELL EFFECTIVENESS AGAINST SOLID TUMORS BY TUMOR-RESTRICTED CYTOKINE DELIVERY VIA IMMUNOCYTOKINES
🕛 12:45 – 12:50
Kathrin Gabriel

LMU Klinikum
Germany

A MODULAR CAR T CELL PLATFORM FOR TARGETED IMMUNOTHERAPY OF ACUTE MYELOID LEUKEMIA

🕛 12:50 – 12:55

Elise Sylvander

BOKU Vienna
Austria

CAFFEINE-REGULATED MOLECULAR SWITCHES FOR FUNCTIONAL CONTROL OF CAR T CELLS

🕛 12:55 – 13:00

Emilia Vigolo

Veneto Institute of Oncology – IOV
Italy

BREAKING THE MATRIX BARRIER: ENHANCING CAR-T CELL ACCESS TO SOLID TUMORS

🕛 13:00 – 13:05

Kersten M. Heyer

Technical University of Munich
Germany

ULTRA-DEEP MURINE EPITOPE-SPECIFIC TCR LIBRARIES IDENTIFY DISPARATE CONTRIBUTIONS OF T CELL RECEPTOR CHAINS AS A COMMON MODE OF FUNCTIONAL EPITOPE RECOGNITION

🕛 13:05 – 13:10

Chiara Chiavelli

University of Modena and Reggio Emilia
Italy

ANTI-GD2 CAR T CELLS EFFICIENTLY TARGET EWING’S SARCOMA

🕛 13:10 – 13:15

Pinar Ataca Atilla

University of Miami
United States of America

TROGOCYTOSIS AND THE PARADOXIMAL IMPACT OF GAMMA SECRETASE INHIBITION ON BCMA CAR T CELLS

🕛 13:15 – 13:20

Koramit Suppipat

Chulalongkorn University
Thailand

LOCOREGIONAL IL-7RΑ–ENHANCED B7-H3 CAR T CELLS (CMD03) IN PEDIATRIC DIPG: PRELIMINARY RESULTS FROM A PHASE I DOSE-ESCALATION TRIAL

🕛 13:20 – 13:25

Maria Chiara Maffia

San Raffaele Scientific Institute
Italy

SINGLE-CELL PROFILING GUIDES A DISEASE-TAILORED TCR-BASED IMMUNOTHERAPY FOR EPITHELIAL OVARIAN CANCER

🕛 13:25 – 13:30

REGISTER HERE
EXPLORE PROGRAM